CN105434695A - A kind of compound Zhixuening dispersible tablet and preparation method thereof - Google Patents

A kind of compound Zhixuening dispersible tablet and preparation method thereof Download PDF

Info

Publication number
CN105434695A
CN105434695A CN201510881588.0A CN201510881588A CN105434695A CN 105434695 A CN105434695 A CN 105434695A CN 201510881588 A CN201510881588 A CN 201510881588A CN 105434695 A CN105434695 A CN 105434695A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine extract
disintegrating agent
dispersible tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510881588.0A
Other languages
Chinese (zh)
Inventor
张昕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heilongjiang Zhicheng Medicine Technology Co Ltd
Original Assignee
Heilongjiang Zhicheng Medicine Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heilongjiang Zhicheng Medicine Technology Co Ltd filed Critical Heilongjiang Zhicheng Medicine Technology Co Ltd
Priority to CN201510881588.0A priority Critical patent/CN105434695A/en
Publication of CN105434695A publication Critical patent/CN105434695A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The compound Zhixuening dispersing tablet is prepared with Chinese medicine extract 10-50 wt%, stuffing 10-80 wt%, inner disintegrating agent 5-5 wt%, outer disintegrating agent 5-15 wt%, corrective 0.1-10 wt%, wetting agent 0.1-20 wt% and lubricant 0.05-20 wt%; in the traditional Chinese medicine extract, the raw materials comprise, by weight, 100 portions of pseudo-ginseng, 200 portions of callicarpa bodinieri, 400 portions of purslane, 200 portions of fried sophora japonica, 10-50 portions of crinis carbonisatus and 50-100 portions of ophicalcitum; the preparation method comprises the following specific steps: step 1, pretreating raw materials; step 2, extracting; step 3, preparing a preparation; and 4, packaging. The compound Zhixuening dispersible tablet has the effects of stopping bleeding, reducing swelling and removing blood stasis. [ b ]

Description

一种复方止血宁分散片及其制备方法A kind of compound Zhixuening dispersible tablet and preparation method thereof

技术领域 technical field

本发明涉及制药技术领域,特别是涉及一种复方止血宁分散片及其制备方法。The invention relates to the technical field of pharmacy, in particular to a compound Zhixuening dispersible tablet and a preparation method thereof.

背景技术 Background technique

功能性子宫出血,简称功血,是一种常见的妇科疾病,是指异常的子宫出血,经诊查后未发现有全身及生殖器官器质性病变,而是由于神经内分泌系统功能失调所致。表现为月经周期不规律、经量过多、经期延长或不规则出血。崩中下血指妇女不在行经期,阴道大量出血,或持续下血淋漓不断,又称“崩中漏下”。Functional uterine bleeding, referred to as dysfunctional uterine bleeding, is a common gynecological disease. It refers to abnormal uterine bleeding. After examination, no organic diseases of the whole body and reproductive organs were found, but it was caused by dysfunction of the neuroendocrine system. . Manifested as irregular menstrual cycle, heavy menstrual flow, prolonged menstruation or irregular bleeding. Metrorrhagia refers to a woman who is not menstruating and has a large amount of vaginal bleeding, or continuous bleeding, which is also called "metrorrhagia".

发明内容 Contents of the invention

本发明的目的是提供一种复方止血宁分散片及其制备方法,具有止血、消肿、化瘀之功效。用于功能性子宫出血,崩中下血,衄血,咳血,吐血等出血症。The object of the present invention is to provide a compound Zhixuening dispersible tablet and a preparation method thereof, which have the effects of hemostasis, detumescence and blood stasis removal. For functional uterine bleeding, metrorrhagia, epistaxis, hemoptysis, hematemesis and other hemorrhagic diseases.

本发明的目的通过以下技术方案来实现:The purpose of the present invention is achieved through the following technical solutions:

一种复方止血宁分散片,由原料按以下重量百分比制备而成,中药提取物10-50%、填充剂10-80%、内加崩解剂5-50%、外加崩解剂5-15%、矫味剂0.1-10%、润湿剂0.1-20%、润滑剂0.05-20%;所述的中药提取物中,原料按重量份数,三七100-200份、紫珠草200-400份、马齿苋200-400份、炒槐花100-200份、血余炭10-50份、花蕊石50-100份。A compound Zhixuening dispersible tablet, which is prepared from raw materials according to the following weight percentages: 10-50% of traditional Chinese medicine extract, 10-80% of filler, 5-50% of internally added disintegrating agent, and 5-15% of externally added disintegrating agent %, flavoring agent 0.1-10%, wetting agent 0.1-20%, lubricant 0.05-20%; in the Chinese medicine extract, the raw materials are 100-200 parts by weight of Panax notoginseng, 200 parts of Zizhucao -400 parts, 200-400 parts of purslane, 100-200 parts of fried Sophora japonica, 10-50 parts of blood charcoal, 50-100 parts of stamen.

所述的中药提取物中,原料按优选重量份数,三七100-120份、紫珠草350-400份、马齿苋350-400份、炒槐花100-150份、血余炭30-50份、花蕊石50-80份。In the traditional Chinese medicine extract, the raw materials are in preferred parts by weight, 100-120 parts of Panax notoginseng, 350-400 parts of Zizhucao, 350-400 parts of purslane, 100-150 parts of fried Sophora japonica, 30 parts of Xue Yu charcoal -50 parts, stamens 50-80 parts.

所述的中药提取物中,原料按最佳重量份数,三七111份、紫珠草370份、马齿苋370份、炒槐花148份、血余炭37份、花蕊石74份。In the Chinese medicine extract, the raw materials are 111 parts by weight of Panax notoginseng, 370 parts of Zizhucao, 370 parts of purslane, 148 parts of fried Sophora japonica, 37 parts of blood charcoal, and 74 parts of stamen.

所述的填充剂为预胶化淀粉、甘露醇、微晶纤维素、蔗糖、乳糖、氯化钠、硫酸钙中的一种或几种的混合;所述内加崩解剂或外加崩解剂为低取代羟丙纤维素、羧甲淀粉钠、交联羧甲基纤维素钠、交联聚维酮中的一种或几种的混合;所述矫味剂为阿司帕坦、甜菊素、枸橼酸、甜橙香精中的一种或几种的混合;所述的润湿剂为水、乙醇溶液中的一种或两种的混合;所述润滑剂为硬脂酸镁、十二烷基硫酸钠、二氧化硅、滑石粉其中的一种或几种的混合。The filler is a mixture of one or more of pregelatinized starch, mannitol, microcrystalline cellulose, sucrose, lactose, sodium chloride, and calcium sulfate; The agent is a mixture of one or more of low-substituted hydroxypropyl cellulose, sodium starch glycolate, croscarmellose sodium, and crospovidone; the flavoring agent is aspartame, stevia One or more of citric acid, sweet orange essence; the wetting agent is water, ethanol solution or a mixture of two; the lubricant is magnesium stearate, One or more of sodium lauryl sulfate, silicon dioxide, and talcum powder.

所述的一种复方止血宁分散片,其制备方法的具体步骤为:Described a kind of compound Zhixuening dispersible tablet, the concrete steps of its preparation method are:

步骤1、原料预处理:按重量份数,选取优质的三七、紫珠草、马齿苋、炒槐花、血余炭、花蕊石,洗净并除杂,备用;Step 1, raw material pretreatment: select high-quality Panax notoginseng, Zizhucao, purslane, fried Sophora japonica, blood residue charcoal, stamens, wash and remove impurities, and set aside;

步骤2、提取:取以上六味中药,将三七、血余炭粉碎成细粉,花蕊石粉碎,混合后先加水煎煮2小时,再加入紫珠草、马齿苋、炒槐花,加水煎煮二次,每次2小时,合并煎液,滤过,滤液减压浓缩至70℃时,相对密度为1.24~1.28的清膏,最后在80℃减压干燥,得中药提取物;Step 2. Extraction: Take the above six traditional Chinese medicines, grind Panax notoginseng and Xueyu charcoal into fine powder, and crush stamens. After mixing, add water and boil for 2 hours, then add Zizhucao, purslane, fried Sophora japonica, add water Decoct twice, each time for 2 hours, combine the decoction, filter, and when the filtrate is concentrated under reduced pressure to 70°C, the relative density is 1.24-1.28, and finally dried under reduced pressure at 80°C to obtain the Chinese medicine extract;

步骤3、制剂:将中药提取物粉碎成细粉,过80目筛,然后加入填充剂、内加崩解剂混合均匀,加入润湿剂,采用流化床制粒技术制粒,制得整粒后,加入外加崩解剂、矫味剂、润滑剂混合均匀,用压片机压片,制成片剂;Step 3, preparation: crush the Chinese medicine extract into fine powder, pass through an 80-mesh sieve, then add a filler and an internal disintegrant to mix evenly, add a wetting agent, and granulate by fluidized bed granulation technology to obtain the whole After granulation, add additional disintegrating agent, corrective agent, lubricant and mix evenly, and compress into tablets with a tablet machine to make tablets;

步骤4、包装:按照片剂规格,分类包装,制成成品。Step 4. Packaging: According to the specifications of the photo agent, it is sorted and packaged to make a finished product.

在上述药物中:三七,散瘀止血,消肿定痛,用于咯血,吐血,衄血,便血,崩漏,外伤出血,胸腹刺痛,跌扑肿痛,紫珠草,散瘀止血,消肿止痛,用于吐血,咯血,衄血,便血,外用治疗外伤出血,马齿苋,有清热利湿、解毒消肿、消炎、止渴、利尿作用,治热痢脓血,热淋,血淋,带下,痈肿恶疮,丹毒,痕疬,便血,子宫出血,有止血作用,槐花(炒),具有清热、凉血、止血、降压的功效,对吐血、尿血、痔疮出血、风热目赤、高血压病、高脂血症、颈淋巴结核、血管硬化、大便带血、糖尿病、视网膜炎、银屑病等有显著疗效,血余炭,收敛止血,化瘀,利尿,用于吐血,咯血,衄血,血淋,尿血,便血,崩漏,外伤出血,小便不利,花蕊石,化瘀止血,用于咯血,吐血,外伤出血,跌扑伤痛。In the above-mentioned medicines: Panax notoginseng, dissipating blood stasis to stop bleeding, reducing swelling and relieving pain, used for hemoptysis, vomiting blood, epistaxis, hematochezia, metrorrhagia, traumatic bleeding, tingling pain in chest and abdomen, tumbling and swelling pain, Zizhucao, dispelling blood stasis Hemostasis, swelling and pain relief, for vomiting blood, hemoptysis, epistaxis, blood in the stool, external treatment of traumatic bleeding, purslane, has the effects of clearing away heat and dampness, detoxifying and reducing swelling, reducing inflammation, quenching thirst, diuresis, and treating dysentery with febrile pus and blood, fever Drenching, bloody stranguria, leukorrhagia, carbuncle, swollen sores, erysipelas, scars, blood in the stool, uterine bleeding, has a hemostatic effect, Sophora japonica (stir-fried), has the effects of clearing away heat, cooling blood, hemostasis, and lowering blood pressure, and is effective for vomiting blood and hematuria , hemorrhoids bleeding, wind-heat red eyes, hypertension, hyperlipidemia, cervical lymphatic tuberculosis, hardening of the arteries, blood in the stool, diabetes, retinitis, psoriasis, etc. have significant curative effect, blood remaining charcoal, astringent and hemostasis, chemical Blood stasis, diuresis, used for vomiting blood, hemoptysis, epistaxis, stranguria, hematuria, hematochezia, metrorrhagia, traumatic bleeding, difficulty urinating, stamen stone, removing blood stasis and hemostasis, used for hemoptysis, hematemesis, traumatic bleeding, tumbling pain.

本发明的有益效果:本发明的一种复方止血宁分散片及其制备方法,具有止血、消肿、化瘀的功效,用于功能性子宫出血,崩中下血,衄血,咳血,吐血等出血症;其溶解性、分散性良好,溶出度高,生物利用度好,体内分布迅速,质量稳定,口感好,服用方便,可吞服,咀嚼,含吮或用水分散后服用,更适合老年人或小儿的患者,具有药物稳定性好,包装,运输,贮藏方便等优点,其制备方法简单易行,适用于工业生产。Beneficial effects of the present invention: a compound Zhixuening dispersible tablet of the present invention and its preparation method have the effects of hemostasis, swelling, and blood stasis, and are used for functional uterine bleeding, metrorrhagia, epistaxis, and hemoptysis. Hematemesis and other hemorrhagic diseases; it has good solubility and dispersibility, high dissolution rate, good bioavailability, rapid distribution in the body, stable quality, good taste, easy to take, can be swallowed, chewed, sucked or taken after dispersing with water, more It is suitable for elderly patients or children, and has the advantages of good drug stability, convenient packaging, transportation and storage, and the preparation method is simple and feasible, and is suitable for industrial production.

本发明的工艺特点:1、选择原料科学,生产工艺先进,其产品方便存放和使用;2、产品中药物成分易被人体吸收;3、原料来源广泛,加工艺线路短,产品易加工制造。The process characteristics of the present invention: 1. Scientific selection of raw materials, advanced production technology, and convenient storage and use of the product; 2. The medicinal ingredients in the product are easily absorbed by the human body; 3. Wide source of raw materials, short processing line, and easy processing and manufacturing of the product.

具体实施方式 detailed description

实施例1Example 1

一种复方止血宁分散片,由原料按以下重量百分比制备而成,中药提取物10-50%、填充剂10-80%、内加崩解剂5-50%、外加崩解剂5-15%、矫味剂0.1-10%、润湿剂0.1-20%、润滑剂0.05-20%;所述的中药提取物中,原料按重量份数,三七100-200份、紫珠草200-400份、马齿苋200-400份、炒槐花100-200份、血余炭10-50份、花蕊石50-100份。A compound Zhixuening dispersible tablet, which is prepared from raw materials according to the following weight percentages: 10-50% of traditional Chinese medicine extract, 10-80% of filler, 5-50% of internally added disintegrating agent, and 5-15% of externally added disintegrating agent %, flavoring agent 0.1-10%, wetting agent 0.1-20%, lubricant 0.05-20%; in the Chinese medicine extract, the raw materials are 100-200 parts by weight of Panax notoginseng, 200 parts of Zizhucao -400 parts, 200-400 parts of purslane, 100-200 parts of fried Sophora japonica, 10-50 parts of blood charcoal, 50-100 parts of stamen.

实施例2Example 2

所述的中药提取物中,原料按优选重量份数,三七100-120份、紫珠草350-400份、马齿苋350-400份、炒槐花100-150份、血余炭30-50份、花蕊石50-80份。In the traditional Chinese medicine extract, the raw materials are in preferred parts by weight, 100-120 parts of Panax notoginseng, 350-400 parts of Zizhucao, 350-400 parts of purslane, 100-150 parts of fried Sophora japonica, 30 parts of Xue Yu charcoal -50 parts, stamens 50-80 parts.

实施例3Example 3

所述的中药提取物中,原料按最佳重量份数,三七111份、紫珠草370份、马齿苋370份、炒槐花148份、血余炭37份、花蕊石74份。In the Chinese medicine extract, the raw materials are 111 parts by weight of Panax notoginseng, 370 parts of Zizhucao, 370 parts of purslane, 148 parts of fried Sophora japonica, 37 parts of blood charcoal, and 74 parts of stamen.

实施例4Example 4

所述的填充剂为预胶化淀粉、甘露醇、微晶纤维素、蔗糖、乳糖、氯化钠、硫酸钙中的一种或几种的混合;所述内加崩解剂或外加崩解剂为低取代羟丙纤维素、羧甲淀粉钠、交联羧甲基纤维素钠、交联聚维酮中的一种或几种的混合;所述矫味剂为阿司帕坦、甜菊素、枸橼酸、甜橙香精中的一种或几种的混合;所述的润湿剂为水、乙醇溶液中的一种或两种的混合;所述润滑剂为硬脂酸镁、十二烷基硫酸钠、二氧化硅、滑石粉其中的一种或几种的混合。The filler is a mixture of one or more of pregelatinized starch, mannitol, microcrystalline cellulose, sucrose, lactose, sodium chloride, and calcium sulfate; The agent is a mixture of one or more of low-substituted hydroxypropyl cellulose, sodium starch glycolate, croscarmellose sodium, and crospovidone; the flavoring agent is aspartame, stevia One or more of citric acid, sweet orange essence; the wetting agent is water, ethanol solution or a mixture of two; the lubricant is magnesium stearate, One or more of sodium lauryl sulfate, silicon dioxide, and talcum powder.

实施例5Example 5

所述的一种复方止血宁分散片,其制备方法的具体步骤为:Described a kind of compound Zhixuening dispersible tablet, the concrete steps of its preparation method are:

步骤1、原料预处理:按重量份数,选取优质的三七、紫珠草、马齿苋、炒槐花、血余炭、花蕊石,洗净并除杂,备用;Step 1, raw material pretreatment: select high-quality Panax notoginseng, Zizhucao, purslane, fried Sophora japonica, blood residue charcoal, stamens, wash and remove impurities, and set aside;

步骤2、提取:取以上六味中药,将三七、血余炭粉碎成细粉,花蕊石粉碎,混合后先加水煎煮2小时,再加入紫珠草、马齿苋、炒槐花,加水煎煮二次,每次2小时,合并煎液,滤过,滤液减压浓缩至70℃时,相对密度为1.24~1.28的清膏,最后在80℃减压干燥,得中药提取物;Step 2. Extraction: Take the above six traditional Chinese medicines, grind Panax notoginseng and Xueyu charcoal into fine powder, and crush stamens. After mixing, add water and boil for 2 hours, then add Zizhucao, purslane, fried Sophora japonica, add water Decoct twice, each time for 2 hours, combine the decoction, filter, and when the filtrate is concentrated under reduced pressure to 70°C, the relative density is 1.24-1.28, and finally dried under reduced pressure at 80°C to obtain the Chinese medicine extract;

步骤3、制剂:将中药提取物粉碎成细粉,过80目筛,然后加入填充剂、内加崩解剂混合均匀,加入润湿剂,采用流化床制粒技术制粒,制得整粒后,加入外加崩解剂、矫味剂、润滑剂混合均匀,用压片机压片,制成片剂;Step 3, preparation: crush the Chinese medicine extract into fine powder, pass through an 80-mesh sieve, then add a filler and an internal disintegrant to mix evenly, add a wetting agent, and granulate by fluidized bed granulation technology to obtain the whole After granulation, add additional disintegrating agent, corrective agent, lubricant and mix evenly, and compress into tablets with a tablet machine to make tablets;

步骤4、包装:按照片剂规格,分类包装,制成成品。Step 4. Packaging: According to the specifications of the photo agent, it is sorted and packaged to make a finished product.

Claims (5)

1. the peaceful dispersible tablet of compound hemostatic, it is characterized in that: be prepared from by following percentage by weight by raw material, Chinese medicine extract 10-50%, filler 10-80%, in disintegrating agent 5-50%, additional disintegrating agent 5-15%, correctives 0.1-10%, wetting agent 0.1-20%, lubricant 0.05-20%; In described Chinese medicine extract, raw materials by weight portion, Radix Notoginseng 100-200 part, Folium Callicarpae Formosanae 200-400 part, Herba Portulacae 200-400 part, Flos Sophorae (parched) 100-200 part, Crinis Carbonisatus 10-50 part, Ophicalcitum 50-100 part.
2. the peaceful dispersible tablet of a kind of compound hemostatic according to claim 1, it is characterized in that: in described Chinese medicine extract, preferred weight number pressed by raw material, Radix Notoginseng 100-120 part, Folium Callicarpae Formosanae 350-400 part, Herba Portulacae 350-400 part, Flos Sophorae (parched) 100-150 part, Crinis Carbonisatus 30-50 part, Ophicalcitum 50-80 part.
3. the peaceful dispersible tablet of a kind of compound hemostatic according to claim 1, it is characterized in that: in described Chinese medicine extract, optimum weight number pressed by raw material, Radix Notoginseng 111 parts, Folium Callicarpae Formosanae 370 parts, Herba Portulacae 370 parts, Flos Sophorae (parched) 148 parts, Crinis Carbonisatus 37 parts, Ophicalcitum 74 parts.
4. the peaceful dispersible tablet of a kind of compound hemostatic according to claim 1, is characterized in that: described filler is the mixing of one or more in pregelatinized Starch, mannitol, microcrystalline Cellulose, sucrose, lactose, sodium chloride, calcium sulfate; With the mixing of one or more that disintegrating agent or additional disintegrating agent are in low-substituted hydroxypropyl cellulose, carboxymethylstach sodium, cross-linking sodium carboxymethyl cellulose, polyvinylpolypyrrolidone in described; Described correctives is the mixing of one or more in aspartame, steviosin, citric acid, orange flavor; Described wetting agent is one or both the mixing in water, alcoholic solution; Described lubricant is the mixing of magnesium stearate, sodium lauryl sulphate, silicon dioxide, Pulvis Talci wherein one or more.
5. the peaceful dispersible tablet of a kind of compound hemostatic according to claim 1-3 any one, is characterized in that: the concrete steps of its preparation method are:
Step 1, pretreatment of raw material: by weight, choose the Radix Notoginseng of high-quality, Folium Callicarpae Formosanae, Herba Portulacae, Flos Sophorae (parched), Crinis Carbonisatus, Ophicalcitum, cleans and remove impurity, for subsequent use;
Step 2, extraction: get above Six-element Chinese medicine, Radix Notoginseng, Crinis carbonisatus powder are broken into fine powder, Ophicalcitum is pulverized, 2 hours are first decocted with water after mixing, add Folium Callicarpae Formosanae, Herba Portulacae, Flos Sophorae (parched) again, decoct with water secondary, each 2 hours, collecting decoction, filter, during filtrate reduced in volume to 70 DEG C, relative density is the clear paste of 1.24 ~ 1.28, last at 80 DEG C of drying under reduced pressure, obtain Chinese medicine extract;
Step 3, preparation: Chinese medicine extract is ground into fine powder, cross 80 mesh sieves, then add filler, in disintegrating agent mix homogeneously, add wetting agent, adopt fluidized bed granulation technology to granulate, after obtained granulate, add additional disintegrating agent, correctives, mix lubricant are even, with tabletting machine, make tablet;
Step 4, packaging: according to tablet format, class wrapping, makes finished product.
CN201510881588.0A 2015-12-07 2015-12-07 A kind of compound Zhixuening dispersible tablet and preparation method thereof Withdrawn CN105434695A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510881588.0A CN105434695A (en) 2015-12-07 2015-12-07 A kind of compound Zhixuening dispersible tablet and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510881588.0A CN105434695A (en) 2015-12-07 2015-12-07 A kind of compound Zhixuening dispersible tablet and preparation method thereof

Publications (1)

Publication Number Publication Date
CN105434695A true CN105434695A (en) 2016-03-30

Family

ID=55545626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510881588.0A Withdrawn CN105434695A (en) 2015-12-07 2015-12-07 A kind of compound Zhixuening dispersible tablet and preparation method thereof

Country Status (1)

Country Link
CN (1) CN105434695A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103860692A (en) * 2014-02-26 2014-06-18 江西祥润科技有限公司 Rapid hemostatic medicament for skin wound
CN104352757A (en) * 2014-11-26 2015-02-18 黑龙江省智诚医药科技有限公司 A kind of dispersible tablet of traditional Chinese medicine for invigorating the kidney and invigorating the spleen and its preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103860692A (en) * 2014-02-26 2014-06-18 江西祥润科技有限公司 Rapid hemostatic medicament for skin wound
CN104352757A (en) * 2014-11-26 2015-02-18 黑龙江省智诚医药科技有限公司 A kind of dispersible tablet of traditional Chinese medicine for invigorating the kidney and invigorating the spleen and its preparation method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中华人民共和国卫生部药典委员会编: "《中华人民共和国卫生部 药品标准 中药成方制剂 第二十册》", 31 December 1998 *

Similar Documents

Publication Publication Date Title
CN104352757A (en) A kind of dispersible tablet of traditional Chinese medicine for invigorating the kidney and invigorating the spleen and its preparation method
CN104383250A (en) A kind of Huajuhong cough dispersible tablet and preparation method thereof
CN104887952B (en) A composition with the effect of nourishing yin and moistening the lung and its preparation method and application
CN104435216A (en) A kind of Maxing cough-relieving traditional Chinese medicine dispersible tablet and preparation method thereof
CN105213974A (en) One treats lymphadenomatous Chinese medicine composition and application thereof
CN107890528A (en) A kind of Chinese medicine composition for treating hyperuricemia and preparation method thereof
CN105380993A (en) Yindanxintai dispersible tablet and preparation method thereof
CN105434695A (en) A kind of compound Zhixuening dispersible tablet and preparation method thereof
CN104436044A (en) A kind of traditional Chinese medicine dispersible tablet for treating coronary heart disease and preparation method thereof
CN106420970A (en) Pharmaceutical composition for curing premature ovarian failure
CN104435138A (en) Paishi traditional Chinese medicine dispersible tablet and preparation method thereof
CN105521332A (en) Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof
CN105106356B (en) A kind of preparation method of Zhijiangning tablet
CN104984097A (en) A kind of traditional Chinese medicine preparation for treating essential hypertension and its application
CN104435710A (en) A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method
CN104740233B (en) A kind of Chinese medicine composition and preparation method thereof
CN105343209A (en) Herba siegesbeckiae rheumatism dispersible tablet and preparation method thereof
CN107715062A (en) One kind is used to treat cardiovascular artery sclerosis Chinese medicine
CN105381040A (en) A kind of Hegan Lidan dispersible tablet and preparation method thereof
CN102018787B (en) Blood pressure lowering capsules and preparation process thereof
CN105287931A (en) A kind of compound Yinhua Kanggan dispersible tablet and preparation method thereof
CN107441313B (en) Traditional Chinese medicine composition, medicine and preparation method for treating decreased ovarian reserve
CN118320030A (en) Compound preparation for treating children dyspepsia and adult stomach diseases and preparation method thereof
CN100384447C (en) Medicament for treating gynecological diseases and preparation method thereof
CN105535658A (en) Traditional Chinese medicine composition for treating dental ulcer and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20160330

WW01 Invention patent application withdrawn after publication